Dotarem

Active Ingredient(s): Gadoterate Meglumine
FDA Approved: * March 20, 2013
Pharm Company: * GUERBET
Category: Diagnostic Aid

Gadoteric acid, sold under the brand name Dotarem among others, is a macrocycle-structured gadolinium-based MRI contrast agent (GBCA). It consists of the organic acid DOTA as a chelating agent, and gadolinium (Gd3+), and is used in form of the meglumine salt (gadoterate meglumine).[3][4] The paramagnetic property of gadoteric acid reduces the T1 relaxation time (and to some extent the T2 and T2* relaxation times) in MRI, which is the source of its clinical uti... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Dotarem 376.9 mg/ml Intravenous Injection
NDC: 67684-2000
Labeler:
Guerbet LLC
Dotarem 376.9 mg/ml Intravenous Injection
NDC: 67684-2001
Labeler:
Guerbet LLC
Dotarem 376.9 mg/ml Intravenous Injection
NDC: 67684-3001
Labeler:
Guerbet LLC

Related Brands

Drugs with the same active ingredients